Enterome
Enterome is a clinical-stage biopharmaceutical company developing off-the-shelf cancer immunotherapies. The company utilizes its OncoMimics platform to trigger immune responses from effector memory T cells to target tumor types including glioblastoma, adrenal tumors, non-Hodgkin lymphoma, and colorectal cancer. Its drug discovery approach focuses on overcoming immune tolerance to self-antigens through microbiome-derived mimicry.
Biotechnology
Oncology
Immunotherapy
Healthcare
Funding summary
- Total raised
- €77.7M
- Funding rounds
- 4
Investors in Enterome
Investors on record for Enterome. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Enterome?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors